{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:16:21Z","timestamp":1784618181444,"version":"3.55.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Healthcare workers were prioritized in vaccination campaigns globally because they are exposed to the highest risk of contamination by SARS-CoV-2. This study evaluated the self-reported post-vaccination side effects of inactivated (BBIBP-CorV and CoronaVac) and adenoviral vector-based (AZD1222, Gam-COVID-Vac and Ad26.COV2.S) vaccines among Algerian healthcare workers using a validated questionnaire. The final analysis included 721 healthcare workers, with a predominance of females (59.1%) and younger individuals 20\u201330 years old (39.4%). Less than half (49.1%) of the respondents reported at least one local side effect, while 53.8% reported at least one systemic side effect. These side effects were more prevalent among viral vector vaccinees than inactivated virus vaccinees. The most common local side effects were injection site pain (39%) and arm pain (25.4%), while fatigue (34.4%), fever (28.4%), headache (24.8%) and myalgia (22.7%) were the most prevalent systemic side effects. The side effects appeared earlier among inactivated virus vaccines recipients and generally lasted for 2 to 3 days for the two vaccinated groups. The risk factors associated with a higher prevalence of side effects included female gender, allergic individuals, individuals with regular medication, those who contracted the COVID-19 disease and those who received two doses for both inactivated and viral-based vaccines groups. Despite the higher prevalence of post-vaccination side effects among adenoviral vector vaccines recipients, both vaccines groups were equally effective in preventing symptomatic infections, and no life-threatening side effects were reported in either vaccine group.<\/jats:p>","DOI":"10.3389\/fpubh.2022.896343","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T06:13:52Z","timestamp":1652681632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers"],"prefix":"10.3389","volume":"10","author":[{"given":"Mohamed","family":"Lounis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Amir","family":"Rais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djihad","family":"Bencherit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani Amir","family":"Aouissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adda","family":"Oudjedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitka","family":"Klugarov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pokorn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miloslav","family":"Klugar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abanoub","family":"Riad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"B1","unstructured":"WHO Coronavirus (COVID-19) Dashboard With Vaccination Data"},{"key":"B2","doi-asserted-by":"publisher","first-page":"CD013574","DOI":"10.1002\/14651858.CD013574","article-title":"Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review","volume":"4","author":"Nussbaumer-Streit","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"n2282","DOI":"10.1136\/bmj.n2282","article-title":"Covid-19: Unvaccinated face 11 times risk of death from delta variant, CDC data show","volume":"374","author":"Dyer","year":"2021","journal-title":"BMJ."},{"key":"B4","unstructured":"Features, Evaluation, and Treatment of Coronavirus (COVID-19) CascellaM RajnikM AleemA DulebohnSC Napoli RDi 32150360Treasure Island (FL)StatPearls PublishingStatPearls2021"},{"key":"B5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/0141076820945282","article-title":"Four months into the COVID-19 pandemic, Sweden's prized herd immunity is nowhere in sight","volume":"113","author":"Orlowski","year":"2020","journal-title":"J R Soc Med."},{"key":"B6","unstructured":"2020"},{"key":"B7","doi-asserted-by":"publisher","first-page":"m2728","DOI":"10.1136\/bmj.m2728","article-title":"Covid-19: Herd immunity is \u201cunethical and unachievable,\u201d say experts after report of 5% seroprevalence in Spain","volume":"370","author":"Griffin","year":"2020","journal-title":"BMJ."},{"key":"B8","doi-asserted-by":"publisher","first-page":"101053","DOI":"10.1016\/j.eclinm.2021.101053","article-title":"Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic","volume":"39","author":"Hotez","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B9","unstructured":"2022"},{"key":"B10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/vaccines9060566","article-title":"Global prevalence and drivers of dental students' COVID-19 vaccine hesitancy","volume":"9","author":"Riad","year":"2021","journal-title":"Vaccines."},{"key":"B11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/vaccines9090954","article-title":"Predictors of willingness to receive COVID-19 vaccine: cross-sectional study of Palestinian dental students","volume":"9","author":"Kateeb","year":"2021","journal-title":"Vaccines."},{"key":"B12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/idr13030064","article-title":"COVID-19 vaccine in pregnant and lactating women: a review of existing evidence and practice guidelines","volume":"13","author":"Garg","year":"2021","journal-title":"Infect Dis Reports."},{"key":"B13","doi-asserted-by":"publisher","first-page":"13373","DOI":"10.3390\/ijerph182413373","article-title":"COVID-19 Vaccine acceptance of pregnant and lactating women (PLW) in Czechia: an analytical cross-sectional study","volume":"18","author":"Riad","year":"2021","journal-title":"Int J Environ Res Public Heal."},{"key":"B14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","article-title":"Hesitant or not? A global survey of potential acceptance of a COVID-19 vaccine","volume":"27","author":"Lazarus","year":"2021","journal-title":"MedRxiv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3390\/vaccines9090948","article-title":"Prevalence and drivers of COVID-19 vaccine hesitancy among Czech University Students: national cross-sectional study","volume":"9","author":"Riad","year":"2021","journal-title":"Vaccines."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.3390\/ijerph18052407","article-title":"Low COVID-19 vaccine acceptance is correlated with conspiracy beliefs among university students in Jordan","volume":"18","author":"Sallam","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/vaccines9101158","article-title":"Iads-Score. Universal predictors of dental students' attitudes towards COVID-19 vaccination: machine learning-based approach","volume":"9","author":"Riad","year":"2021","journal-title":"Vaccines."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1981086","DOI":"10.1080\/21645515.2021.1981086","article-title":"Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study","volume":"18","author":"Omeish","year":"2022","journal-title":"Hum Vaccin Immunother."},{"key":"B19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/vaccines9060556","article-title":"Effects and perceptions following COVID-19 vaccination in Jordan: a randomised, cross-sectional study implementing machine learning for predicting severity of side effects","volume":"9","author":"Hatmal","year":"2021","journal-title":"Vaccines."},{"key":"B20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/vaccines9060577","article-title":"Effects reported by Jordanian healthcare workers who received COVID-19 vaccines","volume":"9","author":"Abu-Hammad","year":"2021","journal-title":"Vaccines."},{"key":"B21","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/vaccines9060674","article-title":"Evaluation of side effects associated with COVID-19 vaccines in Saudi Arabia","volume":"9","author":"Alhazmi","year":"2021","journal-title":"Vaccines."},{"key":"B22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ijid.2021.08.013","article-title":"Side effects and perceptions following Sinopharm COVID-19 vaccination","volume":"111","author":"Saeed","year":"2021","journal-title":"Int J Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3390\/jcm10071428","article-title":"Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic","volume":"10","author":"Riad","year":"2021","journal-title":"J Clin Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/biology10080752","article-title":"Effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers","volume":"10","author":"Klugar","year":"2021","journal-title":"Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3390\/ph14090873","article-title":"Effects of mRNA-based COVID-19 vaccine: nationwide phase iv study among healthcare workers in Slovakia","volume":"14","author":"Riad","year":"2021","journal-title":"Pharm."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/ph14101049","article-title":"Effects of mRNA-based COVID-19 vaccines among young adults (18\u201330 Years Old): an independent post-marketing study","volume":"14","author":"Riad","year":"2021","journal-title":"Pharmaceuticals."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.3390\/jcm10225338","article-title":"Self-reported adverse events of COVID-19 vaccines in Polish healthcare workers and medical students. Cross-sectional study and pooled analysis of CoVaST project results in central Europe","volume":"10","author":"Dziedzic","year":"2021","journal-title":"J Clin Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.3390\/jcm10122629","article-title":"Prevalence and risk factors of CoronaVac side effects: an independent cross-sectional study among healthcare workers in Turkey","volume":"10","author":"Riad","year":"2021","journal-title":"J Clin Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.immuni.2021.06.017","article-title":"COVID-19 vaccine access in Africa: global distribution, vaccine platforms, and challenges ahead","volume":"54","author":"Massinga Loemb\u00e9","year":"2021","journal-title":"Immunity."},{"key":"B30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.35772\/ghm.2021.01117","article-title":"Algeria's preparedness for Omicron variant and for the fourth wave of COVID-19","volume":"3","author":"Aouissi","year":"2021","journal-title":"Glob Heal Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S2213-2600(21)00083-7","article-title":"Algeria's response to COVID-19: an ongoing journey","volume":"9","author":"Klouche-Djedid","year":"2021","journal-title":"Lancet Respir Med."},{"key":"B32","unstructured":"Covid-19: Algeria receives US donation of 604,800 doses of J&J vaccine2021"},{"key":"B33","unstructured":"RoserM RitchieH Ortiz-OspinaE HasellJ Coronavirus Pandemic (COVID-19). Our World Data2020"},{"key":"B34","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"Von Elm","year":"2007","journal-title":"BMJ."},{"key":"B35","doi-asserted-by":"crossref","unstructured":"LounisM Questionnaire sur les effets secondaires des vaccins anti-COVID-19 chez le staff m\u00e9dical en Alg\u00e9rie \u221219. Google Forms2021","DOI":"10.1016\/S1773-035X(22)00206-4"},{"key":"B36","unstructured":"2020"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.3390\/ijerph18157859","article-title":"COVID-19 Vaccines Safety Tracking (CoVaST): protocol of a multi-center prospective cohort study for active surveillance of COVID-19 vaccines' side effects","volume":"18","author":"Riad","year":"2021","journal-title":"Int J Environ Res Public Heal."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association declaration of Helsinki: Ethical principles for medical research involving human subjects","volume":"310","author":"(WMA)","year":"2013","journal-title":"JAMA"},{"key":"B39","unstructured":"IBM SPSS Statistics 282021"},{"key":"B40","doi-asserted-by":"publisher","first-page":"102207","DOI":"10.1016\/j.dsx.2021.102207","article-title":"Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study","volume":"15","author":"Almufty","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3390\/vaccines9111369","article-title":"Unfolding the mild to moderate short-term side effects of four COVID-19 vaccines used in Bahrain: a cross-sectional study","volume":"9","author":"Zahid","year":"2021","journal-title":"Vaccines."},{"key":"B42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/vaccines10020186","article-title":"Which type of the promising COVID-19 vaccines produces minimal adverse effects? A retrospective cross-sectional study","volume":"10","author":"Attash","year":"2022","journal-title":"Vaccines."},{"key":"B43","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/vaccines9090950","article-title":"Qualitative assessment of early adverse effects of Pfizer\u2013BioNTech and Sinopharm COVID-19 vaccines by telephone interviews","volume":"9","author":"Abu-Halaweh","year":"2021","journal-title":"Vaccines."},{"key":"B44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/vaccines10010018","article-title":"SARS-CoV-2 Post vaccinated adverse effects and efficacy in the Egyptian population","volume":"10","author":"Elgendy","year":"2021","journal-title":"Vaccines."},{"key":"B45","first-page":"4418","article-title":"Side effects after COVID-19 vaccinations among residents of Poland","volume":"25","author":"Andrzejczak-Grzadko","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B46","unstructured":"Abdel-Moneim AS. BNT162b2 and ChAdOx1 SARS-CoV-2 post-vaccination side-effects among Saudi vaccinees1796 AlghamdiAN AlotaibiMI AlqahtaniAS Al AboudD 10.3389\/fmed.2021.76004734692740Front Med82021"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/vaccines9101096","article-title":"Adverse events following immunization associated with the first and second doses of the ChAdOx1 nCoV-19 vaccine among healthcare workers in Korea","volume":"9","author":"Jeon","year":"2021","journal-title":"Vaccines."},{"key":"B48","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.2147\/IDR.S332354","article-title":"Adverse effects of the COVID-19 vaccine reported by lecturers and staff of Kabul University of medical sciences, Kabul, Afghanistan","volume":"14","author":"Azimi","year":"2021","journal-title":"Infect Drug Resist."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.2147\/JMDH.S331140","article-title":"COVID-19 vaccine: side effects after the first dose of the Oxford AstraZeneca vaccine among health professionals in low-income country: Ethiopia","volume":"14","author":"Solomon","year":"2021","journal-title":"J Multidiscip Healthc."},{"key":"B50","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/vaccines10030366","article-title":"Reported adverse effects and attitudes among Arab populations following COVID-19 vaccination: a large-scale multinational study implementing machine learning tools in predicting post-vaccination adverse effects based on predisposing factors","volume":"10","author":"Hatmal mon","year":"2022","journal-title":"Vaccines"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-00963-7","article-title":"Side effects and immunogenicity following administration of the Sputnik V COVID-19 vaccine in health care workers in Iran","volume":"11","author":"Babamahmoodi","year":"2021","journal-title":"Sci Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.vaccine.2021.04.013","article-title":"Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race","volume":"40","author":"Kini","year":"2022","journal-title":"Vaccine."},{"key":"B53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/pds.1359","article-title":"Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967\u20131972 study and review of the 1955\u20132005 medical literature","volume":"16","author":"McNeil","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"B54","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Klein SL. Sex and Gender Differences in the Outcomes of Vaccination over the Life Course","volume":"33","author":"Flanagan","year":"2017","journal-title":"Annu Rev Cell Dev Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/vaccines9050522","article-title":"The gender impact assessment among healthcare workers in the SARS-CoV-2 vaccination\u2014an analysis of serological response and side effects","volume":"9","author":"Resta C","year":"2021","journal-title":"Vaccines."},{"key":"B56","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/vaccines9060673","article-title":"Safety of ChAdOx1 nCoV-19 vaccine: independent evidence from two EU States","volume":"9","author":"Riad","year":"2021","journal-title":"Vaccines."},{"key":"B58","doi-asserted-by":"publisher","first-page":"108351","DOI":"10.1016\/j.intimp.2021.108351","article-title":"Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran","volume":"101","author":"Zare","year":"2021","journal-title":"Int Immunopharmacol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.896343\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T08:11:18Z","timestamp":1675584678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.896343\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":58,"alternative-id":["10.3389\/fpubh.2022.896343"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.896343","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"article-number":"896343"}}